Basic Information
Torus Biosystems is developing next-generation POC molecular diagnostic technology for syndromic infectious diseases, which can detect and quantify DNA within 30 minutes. The Synestia™ system employs an integrated testing approach, offering faster and more accurate results than traditional methods. Its mission is to transform patients' lives by providing breakthrough innovations in infectious disease diagnostics.
Torus Biosystems, Inc.
Cambridge,Massachusetts,United States of America
less than 15 people
January 01, 2019
info@torus.bio

